Osteopen 100 mg/ml Solution for injection for dogs
Osteopen 100 mg/ml Solution for injection for dogs
Authorised
- Pentosan polysulfate sodium
Product identification
Medicine name:
Osteopen 100 mg/ml Solution for injection for dogs
Osteopen 100 mg/ml Oplossing voor injectie
Osteopen 100 mg/ml Solution injectable
Osteopen 100 mg/ml Injektionslösung
Active substance:
- Pentosan polysulfate sodium
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Pentosan polysulfate sodium100.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AX90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Colourless glass vial fitted with a grey chlorobutyl stopper and sealed by a lacquered aluminium cap.Package size:1 x 10ml
- Colourless glass vial fitted with a grey chlorobutyl stopper and sealed by a lacquered aluminium cap.Package size:1 x 20ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
- Labiana Life Sciences S.A.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V579457
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0382/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: